Literature DB >> 11383325

PPAR gamma: an essential role in metabolic control.

L Fajas1, M B Debril, J Auwerx.   

Abstract

The peroxisome proliferator-activated receptor gamma is a nuclear hormone receptor playing a crucial role in adipogenesis and insulin sensitization. Prostaglandin J2 derivatives and the antidiabetic thiazolidinediones are its respective natural and synthetic ligands. The RXR/PPAR gamma heterodimer has also been reported to have important immunomodulatory activities and its pleiotropic functions suggest wide-ranging medical implications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383325

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  17 in total

1.  Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.

Authors:  Avani A Pendse; Lance A Johnson; Hyung-Suk Kim; Marcus McNair; C Taylor Nipp; Carolyn Wilhelm; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

2.  Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD).

Authors:  Yuanquan Song; Mary A Selak; Corey T Watson; Christopher Coutts; Paul C Scherer; Jessica A Panzer; Sarah Gibbs; Marion O Scott; Gregory Willer; Ronald G Gregg; Declan W Ali; Michael J Bennett; Rita J Balice-Gordon
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

3.  Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk.

Authors:  Caiyan Wang; Xiaotian Li; Zirong Huang; Jinfeng Qian
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

4.  Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort.

Authors:  Catherine Duggan; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Stephanie George; Rachel Ballard; Marian L Neuhouser; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2017-12-18       Impact factor: 4.872

5.  Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes.

Authors:  Hong Wang; Li Qiang; Stephen R Farmer
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272

Review 6.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

Review 7.  The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.

Authors:  Norman L Eberhardt; Stefan K G Grebe; Bryan McIver; Honey V Reddi
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

8.  Reprogramming of the circadian clock by nutritional challenge.

Authors:  Kristin L Eckel-Mahan; Vishal R Patel; Sara de Mateo; Ricardo Orozco-Solis; Nicholas J Ceglia; Saurabh Sahar; Sherry A Dilag-Penilla; Kenneth A Dyar; Pierre Baldi; Paolo Sassone-Corsi
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

9.  Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats.

Authors:  Sanja Kovačević; Jelena Nestorov; Gordana Matić; Ivana Elaković
Journal:  Eur J Nutr       Date:  2014-01-14       Impact factor: 5.614

Review 10.  Emerging drugs for the treatment of ulcerative colitis.

Authors:  Luca Pastorelli; Theresa T Pizarro; Fabio Cominelli; Maurizio Vecchi
Journal:  Expert Opin Emerg Drugs       Date:  2009-09       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.